KARLSRUHE, Germany – August 5, 2021: Bruker and the Karlsruhe Institute of Technology (KIT), Germany announce the successful installation of the 15.2 Tesla ultra-high field magnetic resonance (MR) imaging system, BioSpec© 152/11. The BioSpec system enables new science at the KIT’s Institute of Microstructure Technology (IMT) under the direction of Professor Jan Korvink. Korvink’s group focuses on the development of novel MRI concepts leading to two visionary goals for the BioSpec: to increase automation of MRI scans, enabling a higher throughput; and to correlate measurements from multiple analytical techniques, increasing information content while decreasing measurement time.
With its focus on natural and engineering sciences, the team at KIT is advancing the fields of energy, mobility, and information by pushing the limits of microscale MR detection. Korvink’s research with the BioSpec© 152/11 will lead to innovations in MR information acquisition and processing that will primarily be used in material research, enabling optimal characterization and development of novel materials.
Prof. Jan Korvink, Head of the Institute of Microstructure Technology at the Karlsruhe Institute of Technology stated
Dr. Wulf. I. Jung, President of Bruker BioSpin’s Preclinical Imaging division
The Karlsruhe Institute of Technology in Karlsruhe, Germany is one of eleven elite Universities of Excellence in Germany. It places a strong emphasis on interdisciplinary collaborations throughout fundamental to applied research. Professor Jan Korvink’s innovative plans for the 15.2 T BioSpec are in full accord with the KIT’s credo of Living the Change.
For more information: https://www.kit.edu/english/
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.
For more information: www.bruker.com/products/mr/preclinical-mri